Last reviewed · How we verify
NCT04898075
Quit Nicotine: E-Cig Cessation Intervention
NA trial testing Remote Contingency Management (CM) for nicotine abstinence in E-Cig Use in 108 participants. Completed in 10 January 2025.
10 January 2025
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 108 |
| Start date | 1 April 2021 |
| Primary completion | 10 January 2025 |
| Estimated completion | 10 January 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Remote Contingency Management (CM) for nicotine abstinence
- Control
Conditions studied
- E-Cig Use — all drugs for E-Cig Use →
Sponsor
Yale University
Who can join
Adults 13 to 20, any sex, with E-Cig Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to find out if a new intervention helps teenagers who vape nicotine quit vaping. The program involves two parts: giving rewards (also called contingency management \[CM\]) and online video counseling (also called cognitive behavioral therapy \[CBT\]).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventions to prevent or cease electronic cigarette use in children and adolescents.
Barnes C, Turon H, McCrabb S, Hodder RK, et al · · 2023 · cited 14× · PMID 37965949 · DOI 10.1002/14651858.cd015511.pub2
Verify or expand the search:
- PubMed search for NCT04898075
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for E-Cig Use
Currently open trials in the same condition.
- NCT07039292 — Clinical Alternatives for Reducing Harm Using E-cigarettes · NA · recruiting
- NCT07167225 — Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study) · recruiting
- NCT06862050 — BREATHE Free: a Pilot Feasibility Trial · NA · recruiting
- NCT06860698 — The Impact of Chronic E-Cigarette Usage on Microvascular Health · recruiting
- NCT05869318 — Respiratory Effects of E-Cigarettes in Obese Youth · NA · active not recruiting
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04898075 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 10 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04898075.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing